The big pharma corporation, Allergan, tried an ingenious way to put its patents where U.S. law couldn’t reach them.
BREAKING NEWS: A federal judge in the Eastern District of Texas invalidated four Allergan patents associated with Restasis in a decision made on October 16, 2017.
“Sovereign immunity should not be treated as a monetizable commodity that can be purchased by private entities as part of a scheme to evade their legal responsibilities,” the judge wrote.
The only sure way to stamp money out of politics is a constitutional amendment.
The Occupy Austin working group, End Corporate Personhood meets to discuss their ongoing petition drive and how to deal with the next Texas Legislative session.